Atlas Trials

The Effect of Sertindole and Risperidone on Endophenotypic Markers of Schizophrenia

Clinical trial NCT02021201 · TERMINATED

Trial details

NCT number
NCT02021201
Sponsor
Birte Glenthoj
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Schizophrenia
Start date
2008-07-01
Primary completion
2013-07-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.